As of 4:00pm ET
| +0.02 / +2.08%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 9.30, with a high estimate of 12.00 and a low estimate of 6.60. The median estimate represents a +848.98% increase from the last price of 0.98.
The current consensus among 3 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.